OpenAI acquires Orchestra Bio to strengthen its life‑sciences AI portfolio. The deal brings Orchestra’s team and technology into OpenAI’s Rosalind model and its Rosalind Workbench platform, which helps researchers design experiments and analyze data. This move signals OpenAI’s push into biotech applications and expands its research tools.
Opening Kapyn…